Trials / Completed
CompletedNCT02218788
Injectable Filler for Facial Soft Tissue Augmentation
An Open-label, Retrospective, Postmarketing Study of Safety and Performance of Hydroxytite, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 218 (actual)
- Sponsor
- Panaxia Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2017-11-01
- Completion
- 2018-08-01
- First posted
- 2014-08-18
- Last updated
- 2019-08-02
Source: ClinicalTrials.gov record NCT02218788. Inclusion in this directory is not an endorsement.